AbbVie CEO says new form of Humira could thwart generics

(Reuters) - An updated experimental form of AbbVie Inc's Humira arthritis drug has clear advantages over the original that could help the company confront looming cheaper biosimilar forms of the blockbuster medication, Chief Executive Richard Gonzalez said in an interview. "It's a fundamental change in the formulation of Humira," Gonzalez said.

via Health News Headlines - Yahoo News Read More Here..